Skip to content

Linda Tempelman

Chief Executive Officer at Persista Bio.

Earliest Form D on file: Apr 2026

Filed Apr 29, 2026

Persista Bio

Implantable cell therapy for Type 1 diabetes

Biotech, City of Lewes DE

Signed as Chief Executive Officer